Methodological Aspects of Protein-Binding Assays for Cyclic AMP in Human Adipose Tissue

References

• Allen D. O., Beck R. B. Alterations in lipolysis, adenylate cyclase and adenosine 3′,5′-monophosphate levels in isolated fat cells following adrenalectomy. Endocrinology 1972; 91: 504
   Google Scholar
• Allen D. O., Clark J. F., Ashmore F. Study of phosphodiesterase inhibitors on lipolysis, phosphodiesterase activity and cyclic 3′,5′-adenosine monophosphate levels in isolated fat cells. J. Pharmacol, exp. Ther. 1973; 185: 379
   Google Scholar
• Allen D. O., Largis E. E., Ashmore J. Antilipolytic action of tolbutamide in isolated fat cells of the rat. Diabetes 1974; 23: 51
   Google Scholar
• Appleman M. M., Birnbaumer L., Torres H. N. Factors affecting the activity of muscle glycogen synthetase III. The reaction with adenosine triphosphate, Mg++ and cyclic 3′,5′-adenosine monophosphate. Arch. Biochem. 1966; 116: 39
   PubMed Web of Science ®Google Scholar
• Brown B. L., Albano I. D. M., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3′,5′-cyclic monophosphate. Biochem. J. 1971; 121: 561
   PubMed Web of Science ®Google Scholar
• Desai K. S., Li K. C., Angel A. Bimodal effect of insulin on hormone stimulated lipolysis: relation to intracellular 3′,5′-cyclic adenylic acid and free fatty acid levels. J. Lipid Res. 1973; 14: 647
   PubMed Web of Science ®Google Scholar
• Fain J. N. Inhibition of adenosine cyclic 3′,5′-monophosphate accumulation in fat cells by adenosine, N6-(phenylisopropyl) adenosine and related compounds. Molec. Pharmacol 1973; 9: 595
   Google Scholar
• Fain J. F., Jacobs M. D., Clement-Cormier Y. C. Interrelationship of cyclic AMP, lipolysis, and respiration in brown fat cells. Amer. J. Physiol. 1973; 224: 346
   Google Scholar
• Fain J. N., Pointer R. H., Ward W. F. Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cyclic adenosine monophosphate accumulation, and lipolysis in fat cells. J. Biol. Chem. 1972; 247: 6866
   PubMed Web of Science ®Google Scholar
• Fain J. N., Psychoyos S., Czernik A. J., Frost S., Cash W. D. Indomethacin, lipolysis and cyclic AMP accumulation in white fat cells. Endocrinology 1973; 93: 632
   Google Scholar
• Gilman A. G. A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc. Not. Acad. Sci. (Wash.) 1970; 67: 305
   PubMed Web of Science ®Google Scholar
• von Günther T., Schmalbeck J., Merker H. J. Gehalt des braunen Fettgewebes der an Noradrenaline und zyklischen AMP im Magnesiummangel. Z. Klin. Chem. 1973; 11: 233
   Google Scholar
• Hittelman K. J., Wu C. F., Butcher R. W. Control of cyclic AMP levels in isolated fat cells from hamsters. Biochim. Biophys. Acta (Amst.) 1973; 304: 188
   Google Scholar
• Jarett L., Smith R. M. Mode of action of N6-02-dibutyryl cyclic 3′,5′ AMP on fat metabolism. Diabetes 1974; 23: 29
   Google Scholar
• Knight B. L., Iliffe J. The effect of glucose, insulin and noradrenaline on lipolysis, and the concentrations of adenosine 3′,5′-cyclic mono-phosphate and adenosine 5′-triphosphate in adipose tissue. Biochem. J. 1973; 132: 11
   Google Scholar
• Kono T., Barham F. W. Effects of insulin on the levels of adenosine 3′,5′-monophos-phate and lipolysis in isolated rat epididymal fat cells. J. Biol. Chem. 1973; 248: 7417
   PubMed Web of Science ®Google Scholar
• Krug F., Parikh I., Illiano Cuatrecacas G., Alpha P. Beta-methylene-adenosine-5′-triphosphate: effects of a competitive inhibitor of adenylate cyclase on cyclic AMP accumulation and lipolysis in isolated fat cells. Biochem. Biophys. Res. Commun. 1973; 50: 985
   Google Scholar
• Lovell-Smith C. J., Sneyd I. G. T. Lipolysis and adenosine 3′,5′-cyclic monophosphate in adipose tissue of the New Zealand obese mouse. J. Endocr. 1973; 56: 1
   Google Scholar
• Murad F., Gilman A. G. Adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate: a simultaneous protein binding assay. Biochim. Biophys. Acta (Amst.) 1971; 252: 397
   Google Scholar
• Murad F., Manganiello V., Vaughan M. A simple, sensitive protein binding assay for guanosine 3′,5′-monophosphate. Proc. Not. Acad. Sci. (Wash.) 1971; 68: 736
   PubMedGoogle Scholar
• Öye I. Cyclic AMP and its relation to clinical chemistry. Scand. J. clin. Lab. Invest. 1973; 32: 189
   PubMed Web of Science ®Google Scholar
• Osnes B., Personal communications
   Google Scholar
• Pawlson L. G., Lovell-Smith C. J., Mangani-Ello V. C., Vaughan M. Effects of epinephrine, adrenocorticotrophin hormone, and theophylline on adenosine 3′,5′-monophosphate phosphodiesterase activity in fat cells. Proc. Not. Acad. Sci. (Wash.) 1974; 71: 1639
   PubMedGoogle Scholar
• Rabinowitz B., Katz J. Method for determination of cyclic AMP in plasma. Clin. Chim. Acta 1973; 19: 312
   Google Scholar
• Ramachandran J., Lees V., Li C. H. Stimulation of lipolysis and cyclic AMP accumulation in rabbit fat cells by human growth hormone. Biochem. Biophys. Res. Commun. 1972; 48: 274
   PubMed Web of Science ®Google Scholar
• Schimmel R. J. Responses of adipose tissue to sequential lipolytic stimuli. Endocrinology 1974; 94: 1372
   PubMedGoogle Scholar
• Schwabe U., Ebert R. Different effects of lipolytic hormones and phosphodiesterase inhibitors on cyclic 3′, 5′-AMP levels in isolated fat cells. Naunyn-Schmiedeberg's Arch. Pharmak. exp. Path. 1972; 274: 287
   Google Scholar
• Schwabe U., Ebert R. Stimulation of cyclic adenosine 3′, 5′-monophosphate accumulation and lipolysis in fat cells by adenosine deaminase. Naunyn-Schmiedeberg's Arch. Pharmak. exp. Path. 1974; 282: 33
   Google Scholar
• Schwabe U., Ebert A., Erbler H. C. Adenosine release from isolated fat cells and its significance for the effects of hormone on cyclic 3′, 5′-AMP levels and lipolysis. NaunynSchmiedeberg's Arch. Pharmak. exp. Path. 1973; 276: 133
   Google Scholar
• Steiner A. L., Kipnis D. M., Utiger R., Parker C. Radioimmunoassay for the measurement of adenosine 3′, 5′-cyclic monophosphate. Biochemistry 1969; 64: 367
   Google Scholar
• Stock K., Prilop M. Dissociation of catecholamine-induced formation of adenosine 3′, 5′-monophosphate and release of glycerol in fat cells by prostaglandin E1, E2 and N6-phenylisopropyladenosine. Neunyn-Schmiedeberg's Arch. Pharmak exp. Path. 1974; 282: 15
   Google Scholar
• Tsang C. P. W., Lehotay D. C. PearsonCyclic AMP Assay 697 Murphy, B. E. Competivitive binding assay for adenosine 3′, 5′-monophosphate employing a bovine adrenal protein: application to urine, plasma and tissues. J. Clin. Endocr. 1972; 35: 809
   PubMed Web of Science ®Google Scholar
• Vaughan M., Steinberg D. Handbook of Physiology. American Physiological Society, Washington, D. C. 1965; 240–241, in Section 5
   Google Scholar
• Walton G. M., Garren L. D. An assay for adenosine 3′, 5′-cyclic monophosphate based on the association of the nucleotide with a partially purified binding protein. Biochemistry 1970; 9: 4223
   PubMedGoogle Scholar
• Weller M., Rodnight R., Carrera D. Determination of adenosine 3′, 5′-cyclic monophosphate in cerebral tissues by saturation analysis. Biochem. J. 1972; 129: 113
   PubMed Web of Science ®Google Scholar
• Wombacher H., Körber F. A simple competitive protein-binding assay for cyclic adenosine 3′, 5′-monophosphate. Z. Klin. Chem. 1972; 10: 260
   Google Scholar